Live Markets  BS Home News Now Markets & Investing Companies & Industry  Portfolio SUN 22 NOV, 2009 02:51 PM FEEDBACK 
  Live Markets* > Company Details
Get Quote Search
Stock Quote Cadila Healthcare Ltd
BSE: Rs 570.85   -1.15 (-0.20%)
November,20 03:55
NSE: Rs 567.6   -4.1 (-0.72%)
November,20 03:56
Sensex
BSENSE
 
Cadila Healthcare Ltd
Sector Gainers
Sector Losers
CompanyLast (Rs)Gain (%)
Titan BioTech25.7010.30
Inwinex Pharma.4.534.86
Saamya Biotech6.704.85
Natco Pharma114.204.48
Mangalam Drugs11.854.22
Welcure Drugs2.673.09
Bal Pharma26.252.94
Glenmark Pharma.254.102.94
(Source: BSE)
 more  
 Financials Results (Quarterly)
 Particulars (Rs lakh) Sep-09 Jun-09
 Sale6439659574
 Other Income11101264
 Total expenses4910443617
 Net profit1244012256
 Equity68246824
 more  
(Source: BSE)
  Broker Calls
Report Name Broker Name Reco Price View
Cadila Healthcare Angel Broking Buy 402
Cadila Healthcare BRICS Buy 253
Cadila Healthcare BRICS Buy 243
Cadila Healthcare Emkay Buy 241
Cadila Healthcare Angel Broking Buy 245
Cadila Healthcare Emkay Buy 258
Cadila Healthcare Angel Broking Buy 310
Cadila Healthcare Religare Buy 302
Cadila Healthcare Religare Buy 290
Cadila Healthcare Angel Broking Buy 271
  Returns (%) more 
Particulars BSE(%) NSE(%) 
One month2.942.10
Six months75.2874.82
One year132.51131.65
(Source: BSE)
 
BSE: 532321 | NSE: CADILAHC
 BSENSE
Open 572.00 573.00
Day High 580.00 581.25
Day Low 568.00 563.00
Previous Close 572.00 571.65
52-Week high 617.95 639.00
52-Week low 223.00 220.00
P/E 20.73 20.65
Market Cap (Rs cr) 7792.1 7747.06
Volume 3603.00 6920.00
 Peer Group
Company Last (Rs) Mkt Cap (Rs cr)
Ranbaxy Labs. 422.45 17758
Cipla 308.95 24013
Sun Pharma.Inds. 1437.00 29763
Biocon 267.90 5358
Piramal Health 400.85 8378
Glenmark Pharma. 254.10 6368
(Source: BSE)
 Company Profile - Cadila Health.
Profile
Chairman & Managing Director: Pankaj R Patel
Site Url: www.zyduscadila.com
Company Address
Zydus Tower
Satellite Cross Roads
Ahmedabad
Phone: 91-079-6868100
Fax: 91-079-6862365/66
 
  Cadila Health. News more 
Zydus Cadila PAT up 39%
Turnaround at operating level for pharma sector
Cadila loses Mexate trademark case
Cadila Healthcare rises 5 per cent
NPPA issues directions to recover Rs 116 cr from drug firms
Cadila rises on Eli Lilly agreement
Zydus Cadila to foray into malted beverage space
  Performance & Analysis more 
ParticularsBSENSE
EPS (Trailing 12 mnths,Rs)26.5026.50
Free Float (%)25.2125.21
FII holding 3.123.12
ROCE(%)18.7318.73
Face Value (in Rs) 5.00
  Shareholding Pattern more 
ParticularsMar-08Dec-07
Indian promoters72.0272.02
Foreign promoters--
Acting person--
Other promoters--
MFs/UTI6.016.09
Banks/FIs9.529.44
FIIs2.972.98
Public corporate bodies0.830.90
Indian public6.846.83
NRIs/OCBs--
Others1.821.74
No of shares125613708125613708
(Source: BSE)
  
Quick Links
Market News Commodities News
Top Gainers Top Losers
52 Week High 52 Week Low
The Smart Investor Broker calls
BSE Notices IPO
 
Stock Name A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
 
Business Standard Network:  Business Standard.com | BSmotoring.com | BShindi.com | E-paper | Portfolios
ABOUT US PARTNER WITH US JOBS@BS ADVERTISE WITH US TERMS & CONDITIONS SITE MAP CONTACT US
Business Standard Ltd. Copyright & Disclaimer feedback@business-standard.com
This site is best viewed with Internet Explorer 6.0 or higher; Firefox 2.0 or higher at a minimum screen resolution of 1024x768
* Stock quotes delayed by 10 minutes or more. All information provided is on "as is" basis and for information purposes only. Kindly consult your financial advisor or stock broker to verify the accuracy and recency of all the information prior to taking any investment decision. While due diligence is done and care taken prior to uploading the stock price data, neither Business Standard Limited, www.business-standard.com nor any independent service provider is/are liable for any information errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.